Compounds and methods for treating neurological and cardiovascular conditions
AssigneesAstrocyte Pharmaceuticals, Inc., The Board of Regents of the University of Texas Sy
InventorsWilliam S. Korinek, James D. Lechleiter, Theodore E. Liston
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries.
Claims21
1-19. (canceled)
A method of treating a brain or central nervous system (CNS) injury or condition comprising administering to a patient in need thereof an effective amount of a compound selected from:
- or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable composition thereof;
- wherein the brain or CNS injury or condition is selected from radiation damage, migraine headache, ischemic stroke, hemorrhagic stroke, subarachnoid hemorrhage, cerebral vasospasm, or transient ischemic attacks (TIA).
A method of treating a neurodegenerative condition, or a condition associated with brain injury or a neurodegenerative condition, comprising administering to a patient in need thereof an effective amount of a compound selected from:
- or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable composition thereof.
A method of treating a heart or cardiovascular disease, comprising administering to a patient in need thereof an effective amount of a compound selected from:
- or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable composition thereof;
- wherein the heart or cardiovascular disease is selected from heart disease, cardiovascular disease, cardiac ischemia, arrhythmia, cardiac ischemia, or myocardial infarction.
A method of treating a disease or condition, comprising administering to a patient in need thereof an effective amount of a compound selected from:
- or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable composition thereof;
- wherein the disease or condition is selected from an autoimmune disease or condition, glaucoma, an otic disorder, progressive hearing loss, tinnitus, collateral brain damage associated with radiation cancer therapy or migraine treatment, epilepsy, pain control, pain mediated by the CNS, neuropathic pain, inflammatory pain, or acute pain.
A method of increasing cardioprotection or regeneration of damaged heart tissue in a patient who has suffered a cardiac ischemia or myocardial infarction, comprising administering to a patient in need thereof an effective amount of a compound selected from
- or a pharmaceutically acceptable salt thereof or a pharmaceutically acceptable composition thereof.
Dependencies are inferred from the claim text.